Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The global enteral feeding formulas market was valued at USD 6.20 Billion in 2024 driven by the rising aging population and prevalence of chronic diseases across the globe. It is further projected to grow at a CAGR of 9.50% during 2025-2034, reaching USD 15.37 Billion in 2034.
Base Year
Historical Period
Forecast Period
The market is expected to expand as the global aging population increases, driving demand for nutritional support for individuals with chronic conditions and age-related diseases.
Technological advancements in enteral feeding formulas, such as improved taste, digestibility, and nutrient composition, are expected to drive market growth, offering more tailored solutions for patients' unique needs.
With rising awareness of malnutrition and increased hospitalization rates, the enteral feeding formulas market will see steady growth, supported by rising healthcare expenditure and improved access to medical nutrition.
The key features of the market report comprise patent analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Danone S.A.: Headquartered in Paris, France, Danone S.A. was established in 1919 and is a global leader in the food and beverage sector, with a strong presence in the enteral feeding formulas market. The company offers a broad range of nutritional products, including specialised enteral formulas under its medical nutrition division. Danone’s portfolio includes brands such as Nutricia, which provides products designed for individuals with specific health needs, such as Paediatrics, oncology, and critical care. Danone’s focus on innovation and nutritional science ensures high-quality products that support patients' recovery and overall well-being, particularly in managing malnutrition.
Nestlé S.A.: Founded in 1867 and headquartered in Vevey, Switzerland, Nestlé S.A. is one of the world's largest food and beverage companies, with a strong foothold in the global enteral feeding formulas market. Nestlé offers a comprehensive range of enteral feeding products under its healthcare nutrition division, including specialised formulas for managing health conditions such as diabetes, cancer, and gastrointestinal issues. Brands like Peptamen and Impact provide tailored solutions for patients in hospitals, long-term care facilities, and home care settings. Nestlé’s commitment to scientific research and nutritional innovation plays a vital role in enhancing patient care through its enteral nutrition offerings.
Abbott: Abbott, established in 1888 and headquartered in Abbott Park, Illinois, USA, is a leading global healthcare company, renowned for its advancements in medical devices, diagnostics, and nutritional products. In the enteral feeding formulas market, Abbott offers a wide range of products designed to meet the nutritional needs of patients with various conditions, including Ensure, a well-known brand offering complete nutrition. Abbott’s enteral nutrition products are widely used in hospitals, home care, and long-term care settings. The company’s ongoing focus on innovation and its commitment to patient-centred care position it as a significant player in the global enteral feeding formulas market.
Mead Johnson & Company, LLC: Mead Johnson & Company, established in 1905 and headquartered in Glenview, Illinois, USA, is a leading player in the global nutritional products market, particularly in the field of enteral feeding formulas. Known for its Enfamil brand, Mead Johnson provides specialised nutritional formulas that support infant and paediatric care, as well as products designed for adult patients with specific dietary needs. The company’s enteral formulas cater to conditions such as malnutrition, metabolic disorders, and chronic illness, with a focus on providing tailored nutritional support to enhance recovery and overall health. Mead Johnson’s commitment to scientific research ensures high-quality, effective products.
Other key players in the market include Fresenius Kabi AG, B. Braun SE, Otsuka Pharmaceutical Co., Ltd., Kate Farms, Meiji Holdings Co., Ltd., and Nutritional Medicinals, LLC.
Enteral Feeding Formulas Market Size
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
In 2024, the global enteral feeding formulas market attained a value of nearly USD 6.20 Billion.
The market is projected to grow at a CAGR of 9.50% between 2025 and 2034.
The market is estimated to witness a healthy growth in the forecast period of 2025-2034 to reach about USD 15.37 Billion by 2034.
The market is being driven by surging demand for enteral feeding formulas by patients affected from chronic diseases like cancer, cardiovascular disorders, and kidney diseases, among others.
Robust research and development and the corresponding development of new products to cater the increasing demand for enteral feeding formulas are pushing the growth of the market.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The major products of enteral feeding formulas are standard formula and disease specific formulas.
The various flow types of enteral feeding formulas are intermittent feeding flow and continuous feeding flow.
The several stages of enteral feeding formulas are adults and paediatrics.
The major indications of enteral feeding formulas are Alzheimer’s, nutrition deficiency, cancer care, diabetes, chronic kidney diseases, orphan diseases, dysphagia, pain management, and malabsorption/GI disorder, and diarrhoea, among others.
The significant end users of enteral feeding formulas are hospitals and home care.
The major players in the industry are Danone S.A., Nestlé S.A., Abbott Nutrition, Mead Johnson & Company, LLC, and Fresenius Kabi AG, among others.
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124